Jeremy Grantham Meridian Bioscience Inc Transaction History

Grantham, Mayo, Van Otterloo & Co. LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$31.15 - $33.39 $3.64 Million - $3.9 Million	116,701 Added 1133.02%	127,001 $4.22 Million
Q3 2022 Nov 10, 2022	SELL	$30.9 - $33.55 $349,170 - $379,114	-11,300 Reduced 52.31%	10,300 $325,000
Q2 2022 Aug 12, 2022	BUY	$23.75 - $31.69 $513,000 - $684,504	21,600 New	21,600 $657,000
Q4 2021 Feb 11, 2022	SELL	$17.46 - $21.61 $735,362 - $910,148	-42,117 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$17.35 - $22.5 $532,645 - $690,750	-30,700 Reduced 42.16%	42,117 $810,000
Q2 2021 Aug 12, 2021	SELL	$18.01 - $28.32 $529,494 - $832,608	-29,400 Reduced 28.76%	72,817 $1.62 Million
Q1 2021 May 13, 2021	SELL	$19.76 - $29.89 $3.14 Million - $4.75 Million	-158,883 Reduced 60.85%	102,217 $2.68 Million
Q4 2020 Feb 12, 2021	SELL	$15.73 - $21.66 $2.43 Million - $3.35 Million	-154,600 Reduced 37.19%	261,100 $4.88 Million
Q3 2020 Nov 13, 2020	BUY	$13.54 - $26.41 $2.16 Million - $4.2 Million	159,200 Added 62.07%	415,700 $7.06 Million
Q2 2020 Aug 13, 2020	BUY	$7.84 - $23.29 $1.66 Million - $4.93 Million	211,500 Added 470.0%	256,500 $5.97 Million
Q1 2020 May 14, 2020	BUY	$5.57 - $11.5 $250,650 - $517,500	45,000 New	45,000 $378,000

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Grantham, Mayo, Van Otterloo & Co. LLC, based on Form 13F filings with the SEC.

Stay updated on Grantham, Mayo, Van Otterloo & Co. LLC and Jeremy Grantham with notifications on news.